Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction
X Li, T Liu, A Bacchiocchi, M Li, W Cheng… - EMBO Molecular …, 2024 - embopress.org
While whole genome sequencing (WGS) of cell-free DNA (cfDNA) holds enormous promise
for detection of molecular residual disease (MRD), its performance is limited by WGS error …
for detection of molecular residual disease (MRD), its performance is limited by WGS error …
Innovations in Short-Read Sequencing Technologies and Their Applications to Clinical Genomics
K Polonis, JH Blommel, AEO Hughes… - Clinical …, 2025 - academic.oup.com
Background Massively parallel sequencing (MPS) of nucleic acids has been a
transformative technology for basic and applied genomic science, increasing efficiencies …
transformative technology for basic and applied genomic science, increasing efficiencies …
[PDF][PDF] African Research Journal of Medical Sciences
MAA Odah - 2024 - afrjms.com
Recent advancements in molecular diagnostics have highlighted the potential of circulating
cell-free DNA (ccfDNA) as a biomarker in various diseases. This study aims to explore the …
cell-free DNA (ccfDNA) as a biomarker in various diseases. This study aims to explore the …
Exploring the Role of Circulating Cell-Free DNA in Disease Diagnosis and Therapy
M Odah - 2024 - preprints.org
Recent advancements in molecular diagnostics have highlighted the potential of circulating
cell-free DNA (ccfDNA) as a biomarker in various diseases. This study aims to explore the …
cell-free DNA (ccfDNA) as a biomarker in various diseases. This study aims to explore the …